Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greenfresh Group is a leading global producer of seaweed-based hydrocolloids, specializing in the manufacture of agar-agar, carrageenan, and konjac-based products. While the company is a major supplier to the food and beverage industry, it maintains a significant presence in the life sciences sector through its production of pharmaceutical-grade agar and carrageenan. These materials are essential for the manufacturing of microbiology culture media, dental impression materials, and as excipients in pharmaceutical drug delivery systems. Headquartered in Zhangzhou, China, and listed on the Hong Kong Stock Exchange, the group operates a vertically integrated business model that includes seaweed cultivation, processing, and dedicated biological technology research. Their products are distributed globally to support laboratory diagnostics, biotechnology research, and pharmaceutical manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Green Fresh Group.